Related Experiment Video

Updated: Jun 27, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Experimental therapeutic strategies for severe sepsis: mediators and mechanisms

William R Parrish1, Margot Gallowitsch-Puerta, Christopher J Czura

  • 1The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA.

Annals of the New York Academy of Sciences
|December 17, 2008
PubMed

Insights

Novel therapies targeting inflammatory mediators and anti-inflammatory pathways show promise for treating severe sepsis, a leading intensive care unit mortality cause. Research focuses on developing effective treatments for sepsis and related inflammatory disorders.

Area of Science:

  • Critical Care Medicine
  • Immunology
  • Pharmacology

Background:

  • Severe sepsis is a primary cause of mortality in intensive care units (ICUs).
  • Current sepsis treatments have limited efficacy in reducing mortality rates.
  • Advances in critical care have improved survival but specific targeted therapies are still needed.

Purpose of the Study:

  • To review current clinical management of severe sepsis.
  • To explore experimental interventions targeting inflammatory mediators and endogenous anti-inflammatory mechanisms.
  • To highlight potential novel therapeutic strategies for sepsis and other inflammatory disorders.

Main Methods:

  • Review of current clinical management approaches for severe sepsis.
  • Analysis of experimental interventions targeting specific inflammatory mediators (caspases, C5a, MIF, HMGB1).
  • Examination of endogenous anti-inflammatory mechanisms, including the cholinergic anti-inflammatory pathway.

Main Results:

  • Targeting pleiotropic or late-acting inflammatory mediators shows potential.
  • Modulating endogenous anti-inflammatory pathways offers therapeutic possibilities.
  • Combined strategies may improve outcomes in severe sepsis.

Conclusions:

  • Specific targeting of pathophysiological mechanisms in sepsis is crucial for improving clinical outcomes.
  • Inflammatory mediators and anti-inflammatory pathways represent promising targets for novel sepsis therapies.
  • Further research into these targets could lead to new treatments for severe sepsis and related disorders.

More Related Videos

Cecal Ligation Puncture Procedure11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

Related Concept Videos

Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...